Division of Cardiac Surgery, University of Verona, Verona, Italy.
Ann Thorac Surg. 2012 Oct;94(4):1173-9. doi: 10.1016/j.athoracsur.2012.04.063. Epub 2012 Jul 15.
Repair of congenital aortic valve (CAV) lesions may be achieved by creation of either tricuspid or bicuspid valve morphology. To define feasibility and outcome of CAV repair by bicuspidization a 10-year experience was reviewed.
Between January 2002 and December 2011, 147 consecutive patients underwent operation for CAV insufficiency; 58 had valve or root repair (group 1) and 89 had valve or root replacement (group 2). Patients having repair were younger (42.9 vs 51.3 years, p=0.001), with lesser prevalence of severe insufficiency (72% vs 90%, p=0.002). In patients having repair, morphology of CAV was bicuspid in 51, monocuspid in 4, and quadricuspid in 3, whereas in the replacement group it was bicuspid in 87 and quadricuspid in 2 (p=0.04). Surgery consisted of an isolated aortic valve procedure in 20 versus 45 patients, associated with aortic root or ascending aortic repair in 38 versus 44 patients, in group 1 versus 2 (p=0.04).
There were no hospital and 3 late deaths during a mean follow-up of 3.8±2.5 years (range 0.2 to 10.0). Eight-year survival (89%±10% vs 97%±2% [p=0.7]), freedom from valve-related events (84%±10% vs 89%±4% [p=0.8]), and freedom from aortic valve reoperation (95%±3% vs 93%±3% [p=0.6]) were comparable. Risk factors for reoperation at univariate analysis were isolated valve surgery (p=0.001), Ross operation (p=0.001), and endocarditis (p=0.002). Follow-up echocardiography of repair patients showed mild or less aortic insufficiency in 51 (88%) and mild or less stenosis in 57 (98%).
Valve repair by preservation or creation of bicuspid morphology is feasible in almost half of all comers with CAV insufficiency, with satisfactory and stable midterm functional outcome. Rates of valve-related adverse events and reoperation are similar to those of patients having replacement.
先天性主动脉瓣(CAV)病变的修复可以通过三尖瓣或二尖瓣形态的形成来实现。为了明确通过二尖瓣化进行 CAV 修复的可行性和结果,回顾了 10 年的经验。
2002 年 1 月至 2011 年 12 月,连续 147 例 CAV 功能不全患者接受手术治疗;58 例行瓣膜或根部修复(组 1),89 例行瓣膜或根部置换(组 2)。行修复术的患者年龄较轻(42.9 岁 vs. 51.3 岁,p=0.001),严重功能不全的发生率较低(72% vs. 90%,p=0.002)。行修复术的患者中,CAV 形态为二尖瓣 51 例,单尖瓣 4 例,四尖瓣 3 例,而行置换术的患者中,二尖瓣 87 例,四尖瓣 2 例(p=0.04)。手术包括单独主动脉瓣手术 20 例,联合主动脉根部或升主动脉修复 38 例,组 1 分别为 45 例和 44 例(p=0.04)。
平均随访 3.8±2.5 年(0.2-10.0 年),无院内死亡,3 例晚期死亡。8 年生存率(89%±10% vs. 97%±2%[p=0.7])、瓣膜相关事件无复发率(84%±10% vs. 89%±4%[p=0.8])和主动脉瓣再手术无复发率(95%±3% vs. 93%±3%[p=0.6])相当。单因素分析显示,再手术的危险因素为单纯瓣膜手术(p=0.001)、Ross 手术(p=0.001)和心内膜炎(p=0.002)。修复患者的随访超声心动图显示,51 例(88%)有轻度或以下主动脉瓣关闭不全,57 例(98%)有轻度或以下狭窄。
在几乎一半的 CAV 功能不全患者中,通过保留或形成二尖瓣形态进行瓣膜修复是可行的,中期功能结果令人满意且稳定。瓣膜相关不良事件和再手术的发生率与行置换术的患者相似。